Close
ACHEMA MIDDLE EAST 2026
DDF Summit 2025

News

      FDA Approves Omvoh by Eli Lilly for Ulcerative Colitis

      Americas
      Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved a new single-injection, once-monthly maintenance option (200 mg/2...

      Novartis to Acquire Avidity Biosciences in $12 Billion Deal

      Americas
      Swiss pharmaceutical company Novartis announced that it has reached an agreement to acquire U.S.-based biotechnology firm Avidity Biosciences in a cash deal valued at...

      AstraZeneca Unveils Expanded Manufacturing Facility in Texas

      Americas
      AstraZeneca has opened an expanded manufacturing facility in Coppell, Texas, following a $445m investment aimed at meeting growing global demand for its hyperkalaemia therapy,...

      FDA Approves Novo Nordisk’s Rybelsus Oral GLP-1 Therapy

      Americas
      Novo Nordisk has announced that the US Food and Drug Administration (FDA) has granted approval for Rybelsus®, the only oral GLP-1 therapy, to reduce...

      FDA Approves Amgen and AstraZeneca’s TEZSPIRE for CRSwNP

      Americas
      Amgen and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has granted approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance therapy...

      FDA Clears Genentech’s Gazyva for Lupus Nephritis in Adults

      Americas
      Genentech, part of the Roche Group, has announced that the U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab) for adults with active...

      FDA Approves Celltrion’s EYDENZELT for Retinal Diseases

      Americas
      Celltrion, Inc. said the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), a biosimilar of EYLEA® (aflibercept), for several retinal conditions. These...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      © 2025 Copyright © Valuemediaservices 2025 All rights reserved.